Consent difficult in paediatric oncologyBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6923.272 (Published 22 January 1994) Cite this as: BMJ 1994;308:272
- O B Eden
- Academic Department of Paediatric Oncology, St Barthlomew's Hospital, London EC1A 7BE.
EDITOR, - Neil McIntosh's comments with regard to the difficulty of obtaining fully informed consent for treatment for neonatal problems are a useful contribution to the current debate.1 They also ring true for paediatric oncologists, who, although committed to the concept of entering patients into randomised trials, often find it difficult to obtain truly informed consent from parents who are emotionally devastated by the recently acquired knowledge that their child has a life threatening condition. Frequently, requests for consent are met with blank stares, anger, or even the comment, You do …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial